{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T04:12:51Z","timestamp":1793160771996,"version":"4.5.0"},"reference-count":46,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,10,7]],"date-time":"2021-10-07T00:00:00Z","timestamp":1633564800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Bioeng. Biotechnol."],"abstract":"<jats:p>Vesicoureteral reflux (VUR) is one of the most common congenital anomalies in the kidney and the urinary tract. Endoscopic subureteral injection of a bulking agent has become popular in VUR treatment due to its high success rates, few complications, and a straightforward procedure. In this study, a novel magnetic bulking agent was prepared by embedding Fe<jats:sub>3<\/jats:sub>O<jats:sub>4<\/jats:sub> magnetic nanoparticles in cross-linked agarose microspheres with diameters of 80\u2013250\u00a0\u03bcm and dispersing the magnetic microspheres in a hyaluronic acid hydrogel. The bulking agent has good biocompatibility and biosecurity validated by the tests of cytotoxicity, <jats:italic>in vitro<\/jats:italic> genotoxicity, animal irritation, skin sensitization, acute systemic toxicity, and pathological analysis after the injection of the bulking agent extract solution into healthy mice as well as injection of the bulking agent into VUR rabbits. The VUR rabbits were created by incising the roof of the intravesical ureter to enlarge the ureteral orifice. The success rate of the bulking agent in treating VUR rabbits using a subureteral transurethral injection technique was 67% (4\/6) or 80% (4\/5, excluding the unfinished rabbit), and no migrated particles were found in the organs of the rabbits. The transverse relaxation rate of the bulking agent was 104\u00a0mM<jats:sup>\u22121<\/jats:sup>s<jats:sup>\u22121<\/jats:sup>. After injection, the bulking agent was long-term trackable through magnetic resonance imaging that can help clinicians to inspect the VUR treatment effect. For the first time, this study demonstrates that the bulking agent with a long-term stable tracer is promising for endoscopic VUR treatment.<\/jats:p>","DOI":"10.3389\/fbioe.2021.746609","type":"journal-article","created":{"date-parts":[[2021,10,9]],"date-time":"2021-10-09T11:08:42Z","timestamp":1633777722000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":7,"title":["Magnetic Agarose Microspheres\/Hyaluronic Acid Hydrogel as a Trackable Bulking Agent for Vesicoureteral Reflux Treatment"],"prefix":"10.3389","volume":"9","author":[{"given":"Hong","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changchun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,10,7]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"174","DOI":"10.22037\/uj.v0i0.4156","article-title":"A Comparison Between Dextranomer\/ Hyaluronic Acid and Polyacrylate Polyalcohol Copolymer as Bulking Agents for Treating Primary Vesicoureteral Reflux","volume":"16","author":"Alizadeh","year":"2019","journal-title":"Urol. J."},{"key":"B2","volume-title":"Laboratory Animal - Requirements of Environment and Housing Facilities (GB14925-2010)","year":"2010"},{"key":"B3","volume-title":"Chinese National Standard of Biological Evaluation of Medical Devices - Part 1: Evaluation and Testing in the Risk Management Process (GB\/T 16886.1-2011\/ISO 10993-1:2009)","year":""},{"key":"B4","volume-title":"Chinese National Standard of Biological Evaluation of Medical Devices - Part 11: Tests for Systemic Toxicity (GB\/T 16886.11-2011\/ISO 10993-11:2006)","year":""},{"key":"B5","volume-title":"Chinese National Standard of Biological Evaluation of Medical Devices - Part 5: Test for","year":""},{"key":"B6","volume-title":"Chinese National Standard of Biological Evaluation of Medical Devices - Part 10: Tests for Irritation and Skin Sensitization (GB\/T 16886.10-2017\/ISO 10993-10:2010)","year":""},{"key":"B7","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1007\/s11934-015-0538-2","article-title":"Controversies in the Management of Vesicoureteral Reflux","volume":"16","author":"Arlen","year":"2015","journal-title":"Curr. Urol. Rep."},{"key":"B8","doi-asserted-by":"publisher","first-page":"1352","DOI":"10.3346\/jkms.2010.25.9.1352","article-title":"Urodynamic and Histological Changes in a Sterile Rabbit Vesicoureteral Reflux Model","volume":"25","author":"Baek","year":"2010","journal-title":"J. Korean Med. Sci."},{"key":"B9","doi-asserted-by":"publisher","first-page":"13","DOI":"10.5489\/cuaj.4342","article-title":"Vesicoureteral Reflux: From Prophylaxis to Surgery","volume":"11","author":"Blais","year":"2017","journal-title":"Can. Urol. Assoc. J."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2008\/513854","article-title":"Endoscopic Treatment of Vesicoureteral Reflux With Dextranomer\/Hyaluronic Acid in Children","volume":"2008","author":"Cerwinka","year":"2008","journal-title":"Adv. Urol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"123","DOI":"10.4274\/jus.galenos.2021.0001","article-title":"Endoscopic Treatment of Vesicoureteral Reflux: Changing Trends Over the Years","volume":"8","author":"Ceylan","year":"2021","journal-title":"J. Urol. Surg."},{"key":"B12","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.jpurol.2009.10.011","article-title":"Long-Term Results of Endoscopic Treatment of Vesicoureteric Reflux With Different Tissue-Augmenting Substances","volume":"6","author":"Chertin","year":"2010","journal-title":"J. Pediatr. Urol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.1056\/NEJMct1108922","article-title":"Endoscopic Treatment of Primary Vesicoureteral Reflux","volume":"366","author":"Diamond","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"B14","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1016\/S0022-5347(05)00210-7","article-title":"Endoscopic Therapy for Vesicoureteral Reflux: a Meta-Analysis. I. Reflux Resolution and Urinary Tract Infection","volume":"175","author":"Elder","year":"2006","journal-title":"J. Urol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"2364","DOI":"10.1016\/j.juro.2008.01.149","article-title":"Incidence of Urinary Tract Infections in Children After Successful Ureteral Reimplantation Versus Endoscopic Dextranomer\/Hyaluronic Acid Implantation","volume":"179","author":"Elmore","year":"2008","journal-title":"J. Urol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1289\/ehp.94102s1115","article-title":"Statistical Characterization of Negative Control Data in the Ames Salmonella\/Microsome Test","volume":"102","author":"Hamada","year":"1994","journal-title":"Environ. Health Perspect."},{"key":"B17","doi-asserted-by":"publisher","first-page":"1628","DOI":"10.1016\/j.juro.2013.09.055","article-title":"Recent Trends in the Surgical Management of Primary Vesicoureteral Reflux in the Era of Dextranomer\/Hyaluronic Acid","volume":"191","author":"Herbst","year":"2014","journal-title":"J. Urol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1007\/s40746-016-0045-9","article-title":"Contemporary Management of Vesicoureteral Reflux","volume":"2","author":"Johnston","year":"2016","journal-title":"Curr. Treat. Options Peds."},{"key":"B19","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/s0094-0143(99)80008-1","article-title":"New Advances in Injectable Therapies for the Treatment of Incontinence and Vesicoureteral Reflux","volume":"26","author":"Kershen","year":"1999","journal-title":"Urol. Clin. North America"},{"key":"B20","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.1002\/jbm.a.36942","article-title":"The Promise of Regenerative Medicine in the Treatment of Urogenital Disorders","volume":"108","author":"Keshel","year":"2020","journal-title":"J. Biomed. Mater. Res."},{"key":"B21","doi-asserted-by":"publisher","first-page":"S38","DOI":"10.4111\/icu.2017.58.S1.S38","article-title":"Endoscopic Injection Therapy","volume":"58","author":"Kim","year":"2017","journal-title":"Investig. Clin. Urol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"206","DOI":"10.4111\/icu.2018.59.3.206","article-title":"New Bulking Agent for the Treatment of Vesicoureteral Reflux: Polymethylmethacrylate\/Dextranomer","volume":"59","author":"Kim","year":"2018","journal-title":"Investig. Clin. Urol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1016\/j.jpurol.2005.12.004","article-title":"Injection Therapy: Advancing the Treatment of Vesicoureteral Reflux","volume":"2","author":"Kirsch","year":"2006","journal-title":"J. Pediatr. Urol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1586\/17434440.2014.929491","article-title":"Evaluation of New Deflux Administration Techniques: Intraureteric HIT and Double HIT for the Endoscopic Correction of Vesicoureteral Reflux","volume":"11","author":"Kirsch","year":"2014","journal-title":"Expert Rev. Med. Devices"},{"key":"B25","doi-asserted-by":"publisher","first-page":"2064","DOI":"10.1021\/cr068445e","article-title":"Magnetic Iron Oxide Nanoparticles: Synthesis, Stabilization, Vectorization, Physicochemical Characterizations, and Biological Applications","volume":"108","author":"Laurent","year":"2008","journal-title":"Chem. Rev."},{"key":"B26","doi-asserted-by":"publisher","first-page":"1869","DOI":"10.1016\/j.juro.2008.12.005","article-title":"Long-Term Followup of Dextranomer\/Hyaluronic Acid Injection for Vesicoureteral Reflux: Late Failure Warrants Continued Followup","volume":"181","author":"Lee","year":"2009","journal-title":"J. Urol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"68","DOI":"10.13523\/j.cb.2015061","article-title":"Research Progress of Agarose in Tissue Engineering","volume":"35","author":"Luo","year":"2015","journal-title":"China Biotechnol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1308\/003588412X13373405386015j","article-title":"Bladder Wrap: a Technique to Restore Continence in an Incompetent Vesicocutaneous Diversion","volume":"94","author":"Mangera","year":"2012","journal-title":"Ann. R. Coll. Surg. Engl."},{"key":"B29","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.jpurol.2007.11.015","article-title":"Endoscopic Treatment of Vesicoureteral Reflux Using Dextranomer Hyaluronic Acid Copolymer","volume":"4","author":"Molitierno","year":"2008","journal-title":"J. Pediatr. Urol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1056\/NEJMra1007755","article-title":"Febrile Urinary Tract Infections in Children","volume":"365","author":"Montini","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"B31","doi-asserted-by":"publisher","first-page":"1794","DOI":"10.1016\/j.juro.2014.05.116","article-title":"Prospective Study of Polydimethylsiloxane vs Dextranomer\/Hyaluronic Acid Injection for Treatment of Vesicoureteral Reflux","volume":"192","author":"Moore","year":"2014","journal-title":"J. Urol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1136\/bmj.289.6436.7","article-title":"Treatment of Vesicoureteric Reflux by Endoscopic Injection of Teflon","volume":"289","author":"O'donnell","year":"1984","journal-title":"Bmj."},{"key":"B33","doi-asserted-by":"publisher","first-page":"2815","DOI":"10.1007\/s00253-020-10412-6","article-title":"Implications of Agar and Agarase in Industrial Applications of Sustainable Marine Biomass","volume":"104","author":"Park","year":"2020","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1016\/j.juro.2010.05.065","article-title":"Summary of the AUA Guideline on Management of Primary Vesicoureteral Reflux in Children","volume":"184","author":"Peters","year":"2010","journal-title":"J. Urol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"3843","DOI":"10.1093\/ndt\/gfr655","article-title":"Novel Perspectives for Investigating Congenital Anomalies of the Kidney and Urinary Tract (CAKUT)","volume":"26","author":"Renkema","year":"2011","journal-title":"Nephrol. Dial. Transplant."},{"key":"B36","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1542\/peds.2009-2225","article-title":"Dextranomer\/Hyaluronic Acid for Pediatric Vesicoureteral Reflux: Systematic Review","volume":"125","author":"Routh","year":"2010","journal-title":"Pediatrics"},{"key":"B37","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1080\/00365590701701632","article-title":"Early Renal Parenchymal Histological Changes in an Experimental Model of Vesico-Ureteral Reflux and the Role of Apoptosis","volume":"42","author":"\u015eencan","year":"2008","journal-title":"Scand. J. Urol. Nephrol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1007\/s00467-006-0349-2","article-title":"Risk of Hypertension in Primary Vesicoureteral Reflux","volume":"22","author":"Simoes","year":"2007","journal-title":"Pediatr. Nephrol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"e20386","DOI":"10.1097\/MD.0000000000020386","article-title":"Risk Factors for Obstructive Complications after Endoscopic Correction of Vesico-Ureteral Reflux Using Polyacrylate Polyalcohol Copolymer","volume":"99","author":"Sizonov","year":"2020","journal-title":"Medicine (Baltimore)."},{"key":"B40","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1016\/j.juro.2010.05.066","article-title":"Pediatric Vesicoureteral Reflux Guidelines Panel Summary Report: Clinical Practice Guidelines for Screening Siblings of Children With Vesicoureteral Reflux and Neonates\/Infants With Prenatal Hydronephrosis","volume":"184","author":"Skoog","year":"2010","journal-title":"J. Urol."},{"key":"B41","first-page":"3305","article-title":"Transverse Relaxation Rates (R2*, R2, and R2') of Iron-Overloaded Livers of Thalassemic Mice at 1.5T and 3T","volume":"14","author":"Song","year":"2006","journal-title":"Proc. Int. Soc. Magn. Reson. Med."},{"key":"B42","doi-asserted-by":"publisher","first-page":"3016","DOI":"10.1016\/j.biomaterials.2010.01.010","article-title":"PET\/NIRF\/MRI Triple Functional Iron Oxide Nanoparticles","volume":"31","author":"Xie","year":"2010","journal-title":"Biomaterials"},{"key":"B43","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1016\/j.matchemphys.2007.02.074","article-title":"Synthesis of Raspberry-Like Magnetic Polystyrene Microspheres","volume":"103","author":"Xu","year":"2007","journal-title":"Mater. Chem. Phys."},{"key":"B44","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.jmmm.2003.10.018","article-title":"Encapsulation of Nanosized Magnetic Iron Oxide by Polyacrylamide via Inverse Miniemulsion Polymerization","volume":"277","author":"Xu","year":"2004","journal-title":"J. Magnetism Magn. Mater."},{"key":"B45","doi-asserted-by":"publisher","first-page":"2015","DOI":"10.1016\/j.jpedsurg.2016.09.028","article-title":"STING Versus HIT Technique of Endoscopic Treatment for Vesicoureteral Reflux: A Systematic Review and Meta-Analysis","volume":"51","author":"Yap","year":"2016","journal-title":"J. Pediatr. Surg."},{"key":"B46","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.mrgentox.2019.05.007","article-title":"The Test That Changed the World: The Ames Test and the Regulation of Chemicals","volume":"841","author":"Zeiger","year":"2019","journal-title":"Mutat. Research\/Genetic Toxicol. Environ. Mutagenesis"}],"container-title":["Frontiers in Bioengineering and Biotechnology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fbioe.2021.746609\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,9]],"date-time":"2021-10-09T11:08:51Z","timestamp":1633777731000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fbioe.2021.746609\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,7]]},"references-count":46,"alternative-id":["10.3389\/fbioe.2021.746609"],"URL":"https:\/\/doi.org\/10.3389\/fbioe.2021.746609","relation":{},"ISSN":["2296-4185"],"issn-type":[{"value":"2296-4185","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,7]]},"article-number":"746609"}}